With 146 Rare Diseases related patents published between 2002 and 2022, Bayer AG holds the most number of Rare Diseases patents in Cuba, of which 45.2% was contributed by its subsidiary Bayer Pharma Aktiengesellschaft.
The second largest number of Rare Diseases related patents were published by Pfizer Inc with 143 patents. The third largest number of Rare Diseases related patents were published by Novartis AG with 135 patents. The fourth largest number of Rare Diseases related patents were published by Les Laboratoires Servier SAS with 44 patents, of which 93.2% was contributed by Servier Laboratories Ltd. The fifth largest number of Rare Diseases related patents were published by AstraZeneca Plc with 24 patents.
The top five patent holders, i.e., Bayer AG, Pfizer Inc, Novartis AG, Les Laboratoires Servier SAS, and AstraZeneca Plc, together held 492 Rare Diseases patents during the period.
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Access more premium companies when you subscribe to Explorer